14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for OTLK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.03 5.00 %
R2 8.89 3.38 %
R1 8.80 2.38 %
Current price: 8.60
Support S1 8.53 -0.87 %
S2 8.44 -1.87 %
S3 8.30 -3.49 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.26 19.30 %
R2 9.37 8.95 %
R1 8.63 0.349 %
Current price 8.60
Support S1 8.51 -1.05%
S2 8.50 -1.16%
S3 8.24 -4.19%

OTLK Predictions History

10 months ago
bandy predicted that OTLK for 2023-06-08 is going

Rank:

10 months ago
JS predicted that OTLK for 2023-06-07 is going $1.77 (-6.35%)

2 years ago
JS predicted that OTLK for 2022-03-09 is going $1.82 (0.00%)

2 years ago
tabithawasserman.299615 predicted that OTLK for 2022-03-09 is going $1.91 (4.95%)

3 years ago
JS predicted that OTLK for 2021-04-28 is going $2.17 (-6.06%)

3 years ago
JS predicted that OTLK for 2021-04-06 is going $2.33 (5.43%)

3 years ago
jduong627 predicted that OTLK for 2021-03-05 is going

Rank:

3 years ago
JS predicted that OTLK for 2021-02-09 is going $2.99 (-3.55%)

3 years ago
Nkolo-Kangkolo Ka predicted that OTLK for 2021-02-09 is going $2.85 (-13.90%)

Rank:

3 years ago
JS predicted that OTLK for 2021-02-08 is going $2.08 (-37.16%)

Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT